Antoine Italiano

Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

S. Sleijfer, F. Collin, M. van Glabbeke, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group.

J. Blay, B. Bui, A. Cesne, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Advanced pleomorphic liposarcomas: clinical outcome and impact of chemotherapy.

B. Bui, A. Italiano, R. Maki, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Correlation between overall survival and growth modulation index in pre-treated sarcoma patients: a study from the French Sarcoma Group.

J. Blay, F. Bertucci, A. Italiano, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Quality of reporting of phase II trials: a focus on highly ranked oncology journals.

S. Mathoulin-Pélissier, A. Italiano, A. Petit-Monéger, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Who are the long responders to imatinib (IM) in patients with advanced GIST? Results of the BFR14 prospective French Sarcoma Group randomized phase III trial.

F. Bertucci, A. Cesne, A. Italiano, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Response to chemotherapy is not related to chromosome instability in synovial sarcoma.

J. Blay, F. Chibon, P. Lagarde, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.